CTLA4‐Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA rats-Reference-Cited by-同舟云学术

CTLA4‐Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA rats

Published:2022-04-25 Issue:4 Volume:28 Page:568-577
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Øvlisen Gabi Overgaard¹²^ORCID,Thygesen Peter¹^ORCID,Weldingh Karin Nana³,Bloem Esther⁴^ORCID,Skov Søren²^ORCID,Almholt Kasper¹^ORCID,Lövgren Karin Maria⁵,Ley Carsten Dan¹^ORCID,Holm Thomas Lindebo⁶^ORCID

Affiliation:

1. Global Drug Discovery Novo Nordisk A/S Maloev Denmark

2. Department of Veterinary and Animal Sciences Faculty of Health and Medical Sciences University of Copenhagen Frederiksberg Denmark

3. Global Discovery and Development Sciences Maloev Denmark

4. Global Research Technologies Novo Nordisk A/S Maloev Denmark

5. Glostrup Research Institute Clinical Experimental Research Glostrup Denmark

6. Clinical Pharmacology Leo Pharma Ballerup Denmark

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14573

Reference28 articles.

1. Clinical severity of haemophilia A: does the classification of the 1950s still stand?

2. Phase I study of BAY 94‐9027, a PEG ylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A

3. Immunogenicity of long-lasting recombinant factor VIII products

4. Factor VIII Products and Inhibitor Development in Severe Hemophilia A

5. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequentmortality, 1977–1999;UHCD Organisation;J Thromb Haemost,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?;Journal of Thrombosis and Haemostasis;2023-11

2. In vivo effect of rFVIII and rFVIIa in hemophilia A rats evaluated by the Tail Vein Transection Bleeding Model;Journal of Thrombosis and Haemostasis;2023-05

3. Optimization of a tail vein transection bleeding model in hemophilia A rats;Journal of Thrombosis and Haemostasis;2023-05